2025 annual financial data
Mereo BioPharma Group 2025 Operating margin
Direct answer
Operating margin was -7,651.4%.
Operating income was -38,257,000 USD and net income was -41,878,000 USD.
Operating cash flow was -30,971,000 USD.
Get free Mereo BioPharma Group email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 500,000 USD
- Operating income
- -38,257,000 USD
- Net income
- -41,878,000 USD
- Operating cash flow
- -30,971,000 USD